Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Real Estate Stats Show Big Wave Of Refinancing Is Coming

Current data released for the May Real Estate and Consumer Spending activity suggests a wave of refinancing is taking place – and not much else. Pending home sales slipped to 69. That level is 7.4 points below the lowest level in 2010 – at the height of the 2008-09 credit cr...
Chris Vermeulen | May 28, 2020 |

'The Rock' Exploring for Copper and Silver in Canada

Gold is about to soar in price because of a worldwide misinformation campaign. So far the effects from the coronavirus are being mostly ignored by the markets. There seems to be hope that this virus will be contained or maybe it is denial of economic damage it will, and c...
Streetwise Reports | February 13, 2020 |

The U.S. Dollar: A global market powerhouse investors can’t ignore

The U.S. dollar isn’t just America’s currency—it’s the backbone of global finance. From trade and debt markets to investment flows, its movements send ripples through economies worldwide. For investors, understanding the dol...
Lyndsay Malchuk | February 14, 2025 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Apple’s Bid To Own Mobile Payments

People paying by using their phone is certainly not new. When ApplePay launched back in October of 2014 there were predictions of millions of payments and billions of dollars being processed. Those predictions were ambitious and it turns out wildly overestim...
Carl Cotton | April 1, 2019 |

Small Caps Setup A Very Rare & Interesting Price Pattern

Our researchers have identified a very rare type of price pattern that is typically associated with explosive trend changes and trends. We call this type of pattern a "Sandwich" pattern because of how price reacts within a range. The IWM, Russell 2000 ETF, is illustrating a ...
Chris Vermeulen | August 6, 2019 |

The Most Influential People of 2019

No one will argue that Donald Trump once again was the most influential person in 2019. He was not alone, however, in what was another exciting year… Bob Mason If we had thought that 2018 was a year to remem...
FX Empire | December 27, 2019 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

How To De-Risk Investing in Junior Battery Metal Exploration Companies: Infographic & Case Study

How To De-Risk Investing in Junior Battery Metal Exploration Companies.
Research | October 3, 2022 |

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Sangamo Therapeutics and partner Pfizer reported positive results for phase 1/2 Alta study for hemophilia A at the International Society on Thrombosis and Hemostasis Congress in Melbourne, Australia. Sangamo Therapeutics Inc. (SGMO:NASDAQ) shares are up...
Streetwise Reports | July 9, 2019 |
1 2 3 4 5 6 7 8 9 10 ...